- Accesswire•12 days ago
NEW YORK, NY / ACCESSWIRE / March 17, 2017 / There has been significant interest in both companies by investment rating firms and individual investors over the past quarter. The interest is not necessarily ...
- Motley Fool•13 days ago
Do Adamas Pharmaceuticals and Amicus Therapeutics have the potential to power your portfolio higher?
- GlobeNewswire•21 days ago
CRANBURY, N.J. and MILAN, Italy, March 08, 2017-- Amicus Therapeutics, a global biotechnology company at the forefront of rare and orphan diseases, has commenced the commercial launch of the precision ...
FOLD : Summary for Amicus Therapeutics, Inc. - Yahoo Finance
Amicus Therapeutics, Inc. (FOLD)
NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
|Bid||6.50 x 300|
|Ask||8.25 x 100|
|Day's Range||7.22 - 7.63|
|52 Week Range||4.41 - 9.83|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-4.95|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|